Genome-wide association studies in Sjögren's syndrome: What do the genes tell us about disease pathogenesis?

Autoimmunity Reviews

Volumn 13, Issue 7, 2014, Pages 756-761

  Burbelo, Peter D ^a   Ambatipudi, Kiran ^a   Alevizos, Ilias ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Autoimmune disease; Candidate genes; Genetics; Genome wide association studies; Polymorphisms; Sj gren's syndrome; SNP

Indexed keywords

ALPHA INTERFERON; BLK KINASE; CHEMOKINE RECEPTOR CXCR5; HLA ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 12; INTERLEUKIN 12P35; LA ANTIBODY; PROTEIN KINASE; RO ANTIBODY; STAT4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GTF2I; TRANSCRIPTION FACTOR TNFAIP3; TRANSCRIPTION FACTOR TNIP; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CD4+ T LYMPHOCYTE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE PRODUCT; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; IMMUNE SYSTEM; PATHOGENESIS; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NF-KAPPA B; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME;

EID: 84898927188     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.02.002     Document Type: Review

References (43)

1. Fox R.I. Sjogren's syndrome. Lancet 2005, 366:321-331.
2. Vitali C., Bombardieri S., Moutsopoulos H.M., Coll J., Gerli R., Hatron P.Y., et al. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome. Ann Rheum Dis 1996, 55:116-121.
3. Shiboski S.C., Shiboski C.H., Criswell L., Baer A., Challacombe S., Lanfranchi H., et al. American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012, 64:475-487.
4. Gottenberg J.E., Cagnard N., Lucchesi C., Letourneur F., Mistou S., Lazure T., et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci U S A 2006, 103:2770-2775.
5. Hjelmervik T.O., Petersen K., Jonassen I., Jonsson R., Bolstad A.I. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum 2005, 52:1534-1544.
6. Wildenberg M.E., van Helden-Meeuwsen C.G., van de Merwe J.P., Drexhage H.A., Versnel M.A. Systemic increase in type I interferon activity in Sjogren's syndrome: a putative role for plasmacytoid dendritic cells. Eur J Immunol 2008, 38:2024-2033.
7. Bave U., Nordmark G., Lovgren T., Ronnelid J., Cajander S., Eloranta M.L., et al. Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005, 52:1185-1195.
8. Bogdanos D.P., Smyk D.S., Rigopoulou E.I., Mytilinaiou M.G., Heneghan M.A., Selmi C., et al. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 2012, 38:J156-J169.
9. Chused T.M., Kassan S.S., Opelz G., Moutsopoulos H.M., Terasaki P.I. Sjogren's syndrome association with HLA-Dw3. N Engl J Med 1977, 296:895-897.
10. Cruz-Tapias P., Rojas-Villarraga A., Maier-Moore S., Anaya J.M. HLA and Sjogren's syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev 2012, 11:281-287.
11. Panagiotou O.A., Ioannidis J.P., Genome-Wide Significance P. What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. Int J Epidemiol 2012, 41:273-286.
12. Korman B.D., Alba M.I., Le J.M., Alevizos I., Smith J.A., Nikolov N.P., et al. Variant form of STAT4 is associated with primary Sjogren's syndrome. Genes Immun 2008, 9:267-270.
13. Palomino-Morales R.J., Diaz-Gallo L.M., Witte T., Anaya J.M., Martin J. Influence of STAT4 polymorphism in primary Sjogren's syndrome. J Rheumatol 2010, 37:1016-1019.
14. Gestermann N., Mekinian A., Comets E., Loiseau P., Puechal X., Hachulla E., et al. STAT4 is a confirmed genetic risk factor for Sjogren's syndrome and could be involved in type 1 interferon pathway signaling. Genes Immun 2010, 11:432-438.
15. Miceli-Richard C., Gestermann N., Ittah M., Comets E., Loiseau P., Puechal X., et al. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjogren's syndrome. Arthritis Rheum 2009, 60:1991-1997.
16. Miceli-Richard C., Comets E., Loiseau P., Puechal X., Hachulla E., Mariette X. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum 2007, 56:3989-3994.
17. Gestermann N., Koutero M., Belkhir R., Tost J., Mariette X., Miceli-Richard C. Methylation profile of the promoter region of IRF5 in primary Sjogren's syndrome. Eur Cytokine Netw 2012, 23:166-172.
18. Wehner R., Dietze K., Bachmann M., Schmitz M. The bidirectional crosstalk between human dendritic cells and natural killer cells. J Innate Immun 2011, 3:258-263.
19. Rusakiewicz S., Nocturne G., Lazure T., Semeraro M., Flament C., Caillat-Zucman S., et al. NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Sci Transl Med 2013, 5:195ra196.
20. Nordmark G., Wang C., Vasaitis L., Eriksson P., Theander E., Kvarnstrom M., et al. Association of genes in the NF-kappaB pathway with antibody-positive primary Sjogren's syndrome. Scand J Immunol 2013, 78:447-454.
21. Nordmark G., Kristjansdottir G., Theander E., Eriksson P., Brun J.G., Wang C., et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren's syndrome. Genes Immun 2009, 10:68-76.
22. Lessard C.J., Li H., Adrianto I., Ice J.A., Rasmussen A., Grundahl K.M., et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome. Nat Genet 2013, 45:1284-1292.
23. Li Y., Zhang K., Chen H., Sun F., Xu J., Wu Z., et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23. Nat Genet 2013, 45:1361-1365.
24. Kliebenstein D. Quantitative genomics: analyzing intraspecific variation using global gene expression polymorphisms or eQTLs. Annu Rev Plant Biol 2009, 60:93-114.
25. Steimle V., Durand B., Barras E., Zufferey M., Hadam M.R., Mach B., et al. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 1995, 9:1021-1032.
26. Wahren-Herlenius M., Dorner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 2013, 382:819-831.
27. Cui Y., Sheng Y., Zhang X. Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun 2013, 41:25-33.
28. Deng Y., Tsao B.P. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 2010, 6:683-692.
29. Wang K., Li M., Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat Rev Genet 2010, 11:843-854.
30. Chan S.H., Perussia B., Gupta J.W., Kobayashi M., Pospisil M., Young H.W., et al. Induction of interferon-gamma production by natural-killer-cell stimulatory factor - characterization of the responder cells and synergy with other inducers. J Exp Med 1991, 173:869-879.
31. Kong H.J., Anderson D.E., Lee C.H., Jang M.K., Tamura T., Tailor P., et al. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol 2007, 179:26-30.
32. Ozato K., Shin D.M., Chang T.H., Morse H.C. TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 2008, 8:849-860.
33. He J., Tsai L.M., Leong Y.A., Hu X., Ma C.S., Chevalier N., et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 2013, 39:770-781.
34. Hansen A., Lipsky P.E., Dorner T. B cells in Sjogren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 2007, 9:218.
35. Ramirez V.P., Gurevich I., Aneskievich B.J. Emerging roles for TNIP1 in regulating post-receptor signaling. Cytokine Growth Factor Rev 2012, 23:109-118.
36. Nocturne G., Boudaoud S., Miceli-Richard C., Viengchareun S., Lazure T., Nititham J., et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome. Blood 2013, 122:4068-4076.
37. Ziakas P.D., Poulou L.S., Thanos L. Towards integrating positron emission tomography for work-up of patients with Sjogren's syndrome and associated lymphomas. Autoimmun Rev 2014, 13:327-329.
38. De Carolis S., Salvi S., Botta A., Garofalo S., Garufi C., Ferrazzani S., et al. The impact of primary Sjogren's syndrome on pregnancy outcome: our series and review of the literature. Autoimmun Rev 2014, 13:103-107.
39. Lee B.H., Gauna A.E., Pauley K.M., Park Y.J., Cha S. Animal models in autoimmune diseases: lessons learned from mouse models for Sjogren's syndrome. Clin Rev Allergy Immunol 2012, 42:35-44.
40. Delaleu N., Nguyen C.Q., Peck A.B., Jonsson R. Sjogren's syndrome: studying the disease in mice. Arthritis Res Ther 2011, 13:217.
41. Vosters J.L., Landek-Salgado M.A., Yin H., Swaim W.D., Kimura H., Tak P.P., et al. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjogren's syndrome. Arthritis Rheum 2009, 60:3633-3641.
42. Singh R.P., Massachi I., Manickavel S., Singh S., Rao N.P., Hasan S., et al. The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 2013, 12:1160-1165.
43. Jonsson R., Theander E., Sjostrom B., Brokstad K., Henriksson G. Autoantibodies present before symptom onset in primary Sjogren syndrome. JAMA 2013, 310:1854-1855.